Skip to main content

Table 3 Results of profiling

From: Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy

Variable

Adult cohort n = 106

Pediatric cohort n = 19

 Valid results

 

104 (98%)

17 (90%)

 

Adult cohort n = 104

Pediatric cohort n = 17

 On-label options only

 

3 (3%)

0

 Off-label options only

 

55 (53%)

11 (65%)

 Both on- and off- label options

 

22 (21%)

0

 Clinical Trial options

Phase I

96 (92%)

14 (82%)

Phase II

76 (73%)

11 (65%)

Phase III

11 (11%)

0